Update of CVM's What's New - Letters to Veterinary Professionals

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Update of CVM's What's New - Letters to Veterinary Professionals

You are subscribed to CVM What's New, for newly posted information on the U.S. Food & Drug Administration's (FDA) Center for Veterinary Medicine's (CVM) Website.

This information has recently been updated and is now available.

Letter to Veterinarians re: INCURIN (estriol) Tablets and PROIN (phenylpropanolamine hydrochloride) Chewable Tablets – http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm277198.htm

 

Letter to Pharmacy Professionals re: INCURIN (estriol) Tablets and PROIN (phenylpropanolamine hydrochloride) Chewable Tablets – http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm277199.htm

 

Letter to Veterinarians re: PRASCEND (pergolide mesylate) Tablets – http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm277207.htm

 

Letter to Pharmacy Professionals re: PRASCEND (pergolide mesylate) Tablets – http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm277208.htm

 

Visit our home page at http://www.fda.gov/AnimalVeterinary/default.htm

 

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420